This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Interleukin 4 (IL4), N-His
Product Overview
BioVenic's Recombinant Equine Interleukin 4 (IL4), N-His is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 16.4 kDa. The purity is greater than 90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.
Specifications
Target Information
Interleukin 4 is encoded by the IL4 gene in horses. It activates plethora of immune cells and induces the humoral immune response.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 20 mM Tris, 150 mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Saini, S. et al. Recombinant horse interleukin-4 and interleukin-10 induced a mixed inflammatory cytokine response in horse peripheral blood mononuclear cells. Veterinary world. 2019, 12: 496-503.